Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival

Annals of Surgical Oncology

Volumn 23, Issue , 2016, Pages 912-920

  Hammad, Abdulrahman Y ^a   Berger, Nick G ^a   Eastwood, Dan ^a   Tsai, Susan ^a   Turaga, Kiran K ^a   Christian, Kathleen K ^a   Johnston, Fabian M ^a,b   Pawlik, Timothy M ^b   Gamblin, T Clark ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; SURVIVAL ANALYSIS; ADJUVANT RADIOTHERAPY; AGE; BILE DUCT TUMOR; CANCER GRADING; CANCER STAGING; FACTUAL DATABASE; INTRAHEPATIC BILE DUCT; LYMPH NODE METASTASIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY; SURGICAL MARGIN; SURVIVAL RATE;

AGE FACTORS; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MARGINS OF EXCISION; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROPENSITY SCORE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84988664224     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-016-5560-1     Document Type: Article

References (23)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005; 366: 1303–14.
2. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004; 24: 115–25.
3. Yeh CN, Hsieh FJ, Chiang KC, Chen JS, Yeh TS, Jan YY, Chen MF. Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma. Drug Des Devel Ther. 2015; 9: 163–74.
4. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005; 241: 715–24
5. Poon RT, Fan ST, Ng IO, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg. 2000; 231: 544–51.
6. Bergstralh EJ, Kosanke J. Computerized matching of controls. Section of biostatistics technical report 56. Rochester, MN, Mayo Foundation, 1995.
7. Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012; 30: 1934–40.
8. Miura JT, Johnston FM, Tsai S, et al. Chemotherapy for surgically resected intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015; 22: 3716–23.
9. Murakami S, Ajiki T, Okazaki T, et al. Factors affecting survival after resection of intrahepatic cholangiocarcinoma. Surg Today. 2014; 44: 1847–54.
10. Sur MD.., In H, Sharpe SM, Baker MS, Weichselbaum RR, Talamonti MS, Posner MC. Defining the benefit of adjuvant therapy following resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015; 22: 2209–17.
11. Todoroki T, Ohara K, Kawamoto T, et al. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys. 2000; 46: 581–7.
12. Stein DE, Heron DE, Rosato EL, Rosato EL, Anné PR, Topham AK. Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol. 2005; 28: 21–3.
13. Bonet Beltrán M, Allal AS, Gich I, Solé JM, Carrió I. Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies. Cancer Treat Rev. 2012; 38: 111–9.
14. Shinohara ET, Mitra N, Guo M, Metz JM. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2008; 72: 1495–501.
15. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001; 193: 384–91.
16. Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015; 22: 4020–8.
17. Clark CJ, Wood-Wentz CM, Reid-Lombardo KM, Kendrick ML, Huebner M, Que FG. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB (Oxford). 2011; 13: 612–20.
18. Vitale A, Moustafa M, Spolverato G, Gani F, Cillo U, Pawlik TM. Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2016; 113: 685–91.
19. Spolverato G, Vitale A, Cucchetti A, et al. Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer. 2015; 121: 3998–4006.
20. Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol. 2013; 5: 81–7.
21. Koshy M, Malik R, Mahmood U, Husain Z, Sher DJ. Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer. Radiother Oncol. 2015; 114: 148–54.
22. Sherman KL, Merkow RP, Bilimoria KY, Wang CE, Mulcahy MF, Benson AB, Bentrem DJ. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol. 2013 ;20:362–70.
23. Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL. National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database. Cancer Med. 2015; 4: 1828–35.